Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 75 of 99 entries
View as:

Crossover Bioequivalence Study of Oxcarbazepine 600 mg Suspension Under Fed Conditions

Phase: N/A Priority: Normal
NCT ID: NCT01703468 Org: User:
Start: 09/30/09 End: 10/31/09 Due: 10/31/10

Bioequivalency Study of Protriptyline 10 mg Tablets Under Fasted Conditions

Phase: N/A Priority: Normal
NCT ID: NCT00754962 Org: User:
Start: 12/31/06 End: 01/31/07 Due: 01/31/08

Crossover Bioequivalence Study of Quetiapine Fumarate 300 mg Tablets Under Steady State Fasted Conditions

Phase: N/A Priority: Normal
NCT ID: NCT01570959 Org: User:
Start: 04/30/07 End: 11/30/07 Due: 11/30/08

Bioequivalency Study of Amlodipine Tablets Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT00602017 Org: User:
Start: 04/30/04 End: 05/31/04 Due: 05/31/05

Bioequivalency Study of Balsalazide Capsules Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT00618228 Org: User:
Start: 01/31/04 End: 01/31/04 Due: 01/31/05

Bioequivalency Study of Losartan Potassium/Hydrochlorothiazide 100 mg/25 mg Tablet Under Fasted Conditions

Phase: N/A Priority: Normal
NCT ID: NCT01102478 Org: User:
Start: 02/28/05 End: 03/31/05 Due: 03/31/06

Crossover Bioequivalence Study of Irbesartan 300 mg Tablets Under Fasted Conditions

Phase: N/A Priority: Normal
NCT ID: NCT01712113 Org: User:
Start: 08/31/07 End: 08/31/07 Due: 08/31/08

A Single Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Balsalazide Disodium 750 mg Capsules Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT00618202 Org: User:
Start: 05/31/05 End: 06/30/05 Due: 06/30/06

Bioequivalency Study of Exemestane 25 mg Tablet Under Fasted Conditions

Phase: N/A Priority: Normal
NCT ID: NCT01331421 Org: User:
Start: 07/31/04 End: 08/31/04 Due: 08/31/05

Bioequivalency Study of Montelukast Chewable 5 mg Tablets Under Fasted Conditions

Phase: N/A Priority: Normal
NCT ID: NCT01659905 Org: User:
Start: 08/31/08 End: 08/31/08 Due: 08/31/09

Bioequivalency Study of 450 mg Lithium Carbonate Under Fed Conditions

Phase: N/A Priority: Normal
NCT ID: NCT00601575 Org: User:
Start: 10/31/02 End: 11/30/02 Due: 11/30/03

Pharmacokinetic and Comparative Bioavailability Study of Codeine Sulfate Under Fasted Conditions

Phase: N/A Priority: Normal
NCT ID: NCT01010139 Org: User:
Start: 08/31/06 End: 09/30/06 Due: 09/30/07

Bioequivalency Study of Amlodipine Tablets Under Fed Conditions

Phase: N/A Priority: Normal
NCT ID: NCT00601302 Org: User:
Start: 04/30/04 End: 05/31/04 Due: 05/31/05

Bioequivalency Study of Exemestane 25 mg Tablet Under Fed Conditions

Phase: N/A Priority: Normal
NCT ID: NCT01331434 Org: User:
Start: 10/31/04 End: 10/31/04 Due: 10/31/05

Bioequivalency Study of 300 mg Lithium Carbonate Under Fed Conditions

Phase: N/A Priority: Normal
NCT ID: NCT00602394 Org: User:
Start: 05/31/03 End: 05/31/03 Due: 05/31/04

Bioequivalency Study of Levetiracetam 750 mg Tablets Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT00826865 Org: User:
Start: 08/31/05 End: 08/31/05 Due: 08/31/06

Dose Proportionality and Food Effect of Morphine Sulfate

Phase: N/A Priority: Normal
NCT ID: NCT00994539 Org: User:
Start: 01/31/07 End: 02/28/07 Due: 02/28/08

Bioequivalency Study of 7.5 mg Pilocarpine Tablets Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT00602524 Org: User:
Start: 08/31/04 End: 08/31/04 Due: 08/31/05

Bioequivalency Study of Oxymorphone Hydrochloride 10 mg Tablets Under Fasted Conditions

Phase: N/A Priority: Normal
NCT ID: NCT01210638 Org: User:
Start: 06/30/08 End: 06/30/08 Due: 06/30/09

Bioequivalence Study of 6-Mercaptopurine Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT00602134 Org: User:
Start: 11/30/02 End: 11/30/02 Due: 11/30/03

Bioequivalency Study of Buprenorphine Hydrochloride 8 mg Tablet Under Fasted Conditions

Phase: N/A Priority: Normal
NCT ID: NCT00992095 Org: User:
Start: 08/31/06 End: 09/30/06 Due: 09/30/07

Crossover Bioequivalence Study of Tinidazole 500 mg Tablets Under Fed Conditions

Phase: N/A Priority: Normal
NCT ID: NCT01591889 Org: User:
Start: 09/30/09 End: 09/30/09 Due: 09/30/10

Bioequivalency Study of Ramipril 10 mg Capsules Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT00702091 Org: User:
Start: 01/31/05 End: 01/31/05 Due: 01/31/06

Bioequivalency Study of Oxcarbazepine 600 mg Tablets Under Fed Conditions

Phase: N/A Priority: Normal
NCT ID: NCT00616863 Org: User:
Start: 07/31/04 End: 07/31/04 Due: 07/31/05

Bioequivalency Study of Meloxicam Tablets Under Fed Conditions

Phase: N/A Priority: Normal
NCT ID: NCT00601887 Org: User:
Start: 03/31/05 End: 04/30/05 Due: 04/30/06